Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Truncated ACE2 fusion protein targets RAS overactivity in renal diseases

Nov. 21, 2019

New phase III trial in Japan studies KW-3357 to treat early-onset pre-eclampsia

Nov. 20, 2019

Amgen identifies novel apelin receptor agonists

Nov. 20, 2019

Phase III study of vericiguat in worsening chronic heart failure meets primary endpoint

Nov. 20, 2019

RQ-00490721 prevents cardiac dysfunction in mouse model of heart failure

Nov. 20, 2019

First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI

Nov. 18, 2019

Gut bacteria can drive heart autoimmunity

Nov. 18, 2019

Bellerophon reports initial data from acute hemodynamic study of INOpulse

Nov. 13, 2019

Cerecor announces milestones in clinical development programs of CERC-301 and CERC-802

Nov. 12, 2019

Terns patents new MAP3K5 inhibitors

Nov. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...